Judy Morona

Research Interests

Cancer Biology and Clinical Oncology Innovative Therapeutics Translational Health Outcomes Medical and Health Sciences

Dr Judy Morona

Senior Health Technology Assessment Analyst

School of Public Health

College of Health

Date Institution name Country Title
2008 - 2010 University of Adelaide Australia Graduate Diploma in Public Health
1995 - 1999 University of Adelaide Australia PhD

Year Citation
2017 Kessels, S. J. M., Newton, S. S., Morona, J. K., & Merlin, T. L. (2017). Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease: A Systematic Review. Journal of Clinical Gastroenterology, 51(9), 777-788.
DOI Scopus16 WoS15 Europe PMC12
2013 Morona, J., Buckley, E., Jones, S., Reddin, E., & Merlin, T. (2013). Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis. Diabetes-Metabolism Research and Reviews, 29(3), 183-193.
DOI Scopus95 WoS77 Europe PMC59
2011 Byrne, J., Morona, J., Paton, J., & Morona, R. (2011). Identification of Streptococcus pneumoniae Cps2C residues that affect capsular polysaccharide polymerization, cell wall ligation, and Cps2D phosphorylation. Journal of Bacteriology, 193(9), 2341-2346.
DOI Scopus18 WoS14 Europe PMC13
2006 Morona, J., Morona, R., & Paton, J. (2006). Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proceedings of the National Academy of Sciences of the United States of America, 103(22), 8505-8510.
DOI Scopus114 WoS102 Europe PMC92
2004 Morona, J., Miller, D., Morona, R., & Paton, J. (2004). The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. Journal of Infectious Diseases, 189(10), 1905-1913.
DOI Scopus113 WoS107 Europe PMC100
2003 Morona, J., Morona, R., Miller, D., & Paton, J. (2003). Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. Journal of Bacteriology, 185(10), 3009-3019.
DOI Scopus82 WoS73 Europe PMC65
2002 Morona, J., Morona, R., Miller, D., & Paton, J. (2002). Streptococcus pneumoniae capsule biosynthesis protein CpsB is a novel manganese-dependent phosphotyrosine-protein phosphatase. Journal of Bacteriology, 184(2), 577-583.
DOI Scopus112 WoS100 Europe PMC90
2000 Morona, J., Paton, J., Miller, D., & Morona, R. (2000). Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Molecular Microbiology, 35(6), 1431-1442.
DOI Scopus197 WoS180 Europe PMC166
1999 Morona, J., Miller, D., Coffey, T., Vindurampulle, C., Spratt, B., Morona, R., & Paton, J. (1999). Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 23F. Microbiology - UK, 145(4), 781-789.
DOI Scopus29 WoS23 Europe PMC21
1999 Morona, J., Morona, R., & Paton, J. (1999). Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types beloning to serogroup 19. Journal of Bacteriology, 181(17), 5355-5364.
DOI Scopus57 WoS53 Europe PMC48
1999 Morona, J., Morona, R., & Paton, J. (1999). Analysis of the 5' portion of the type 19A capsule locus identifies two classes of cpsC, cpsD, and cpsE genes in Streptococcus pneumoniae. Journal of Bacteriology, 181(11), 3599-3605.
DOI Scopus42 WoS36 Europe PMC32
1998 Coffey, T., Enright, M., Daniels, M., Morona, J., Morona, R., Hryniewicz, W., . . . Spratt, B. (1998). Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae.. Molecular Microbiology, 27(1), 73-83.
DOI Scopus283 WoS257 Europe PMC212
1997 Paton, J., Morona, J., & Morona, R. (1997). Characterization of the Capsular Polysaccharide Biosynthesis Locus of Streptococcus pneumoniae Type 19F. Microbial Drug Resistance-Mechanisms Epidemiology and Disease, 3(1), 89-99.
DOI Scopus4 WoS5 Europe PMC4
1997 Morona, J., Morona, R., & Paton, J. (1997). Molecular and Genetic Characterization of the Capsule Biosynthesis Locus Of Streptococcus pneumoniae Type 19B. Journal of Bacteriology, 179(15), 4953-4958.
DOI Scopus38 WoS35 Europe PMC32
1997 Morona, J., Morona, R., & Paton, J. (1997). Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biuosynthetic pathway. Molecular Microbiology, 23(4), 751-763.
DOI Scopus103 WoS100 Europe PMC81
1995 Guildolin, A., Morona, J. K., Morona, R., Hansman, D., & Paton, J. C. (1995). Nucleotide sequence analysis of genes essential for production of Streptococcus pneumoniae type 19F capsular polysaccharide.. Developments in Biological Standardization, 85, 267-271.
Scopus3 WoS3 Europe PMC3
1994 Guidolin, A., Morona, J. K., Morona, R., Hansman, D., & Paton, J. C. (1994). Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infection and Immunity, 62(12), 5384-5396.
DOI Scopus121 WoS119 Europe PMC96
1994 Morona, J. K., Guidolin, A., Morona, R., Hansman, D., & Paton, J. C. (1994). Isolation, characterization, and nucleotide sequence of IS1202, an insertion sequence of Streptococcus pneumoniae. Journal of Bacteriology, 176(14), 4437-4443.
DOI Scopus34 WoS39 Europe PMC24
1994 Morona, R., Morona, J. K., Considine, A., Hackett, J. A., van den Bosch, L., Beyer, L., & Attridge, S. R. (1994). Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs. Vaccine, 12(6), 513-517.
DOI Scopus22 WoS15 Europe PMC15
1993 Paton, J. C., Morona, J. K., Harrer, S., Hansman, D., & Morona, R. (1993). Immunization of mice with Salmonella typhimurium C5 aroA expressing a genetically toxoided derivative of the pneumococcal toxin pneumolysin. Microbial Pathogenesis, 14(2), 95-102.
DOI Scopus9 WoS9 Europe PMC4
1991 Morona, R., Yeadon, J., Considine, A., Morona, J. K., & Manning, P. A. (1991). Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine development. Gene, 107(1), 139-144.
DOI Scopus39 WoS34 Europe PMC26
1990 Attridge, S. R., Daniels, D., Morona, J. K., & Morona, R. (1990). Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microbial Pathogenesis, 8(3), 177-188.
DOI Scopus18 WoS22 Europe PMC18
1990 Morona, R., Matthews, M. S., Morona, J. K., & BrownBrownBrown, M. H. (1990). Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen. MGG Molecular General Genetics, 224(3), 405-412.
DOI Scopus5 WoS3 Europe PMC3

Year Citation
2018 Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium (2018). Poster session presented at the meeting of Diagnostic and Prognostic Research. Springer Science and Business Media LLC.
DOI
2015 Morona, J. K., Newton, S., & Merlin, T. L. (2015). Meta-analysis of Two Tests via a Common Reference Standard for Detection of Tuberculosis Infections. Poster session presented at the meeting of 12th Annual Health Technology Assessment International (HTAi) Conference. Oslo, Norway.
2015 Kessels, S., Morona, J. K., Newton, S. S., & Merlin, T. L. (2015). The impact of an imperfect reference standard. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway.
2014 Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Poster session presented at the meeting of the 11th Annual Health Technology Assessment international (HTAi) Conference. Washington D.C., USA.
2014 Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster session presented at the meeting of the 36th Annual North American Meeting Society for Medical Decision Making (SMDM). Miami, USA.
2013 Morona, J. K., Buckley, E. S., Reddin, E. A., & Merlin, T. L. (2013). The use of growth factors to promote healing of diabetic foot ulcers: A Systematic Review.. Poster session presented at the meeting of 2013 Australasian Cochrane Symposium. Melbourne, VIC.
2013 Morona, J., Newton, S. S., Ellery, B., & Merlin, T. (2013). Genetic testing for VHL disease: limited benefit to the individual, but reduced surveillance for family members. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea.
2008 Morona, J. K., Morona, R., & Paton, J. C. (2008). Comparison of Streptococcus pneumoniae Polysaccharide Polymerase Proteins Cps19aI and Cps19fI. Poster session presented at the meeting of FASEB Summer Research Conferences: Microbial Polysaccharides of Medical, Agricultural and Industrial Importance. Carefree, Arizona, USA.
2007 Morona, J. K., Morona, R., & Paton, J. C. (2007). Comparison of Streptococcus pneumoniae Polysaccharide Polymerase Proteins Cps19aI and Cps19fI. Poster session presented at the meeting of Ninth Australian Conference on Molecular Biology of Bacterial Pathogens. Lorne, Victoria, Australia.
2006 Morona, J. K., Morona, R., & Paton, J. C. (2006). Mutation of the Conserved Capsular Polysaccharide Biosynthesis Gene cpsB of Streptococcus pneumoniae D39 results in two distinct CPS phenotypes.. Poster session presented at the meeting of The 5th International Symposium on Pneumococci and Pneumococcal Diseases. Alice Springs, Northern Territory, Australia.
2000 Morona, J. K., Morona, R., Miller, D. C., & Paton, J.C.. (2000). Mutation analysis of the carboxy-terminal [YGX]4 repeat domain of CpsD, a Streptococcus pneumoniae capsule biosynthesis protein. Poster session presented at the meeting of FASEB Summer Research Conferences: Microbial Polysaccharides of Medical, Agricultural and Industrial Importance. Copper Mountain, Colorado, USA.
1999 Morona, J. K., Morona, R., & Paton, J. C. (1999). Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19. Poster session presented at the meeting of Fifth Australian Conference on Molecular Analysis of Bacterial Pathogens. Victor Harbor, SA., Australia.
1998 Paton, J. C., Morona, J. K., & Morona, R. (1998). Characterisation of the capsule biosynthesis loci of pneumococci belonging to serogroup 19. Poster session presented at the meeting of First International symposium on Pneumococci and pneumococcal Diseases. Elsinore, Denmark.
1997 Morona, J. K., Morona, R., & Paton, J. C. (1997). Molecular and genetic characterisation of the capsule biosynthesis locus of Streptococcus pneumoniae type 19B. Poster session presented at the meeting of Fourth Australian Conference on Molecular Analysis of Bacterial Pathogens. Jamberoo, NSW. Australia.
1997 Paton, J. C., Morona, J. K., & Morona, R. (1997). Molecular analysis of capsular polysaccharide biosynthesis (cps) loci of Streptococcus pneumoniae.. Poster session presented at the meeting of Microbiology Australia. Adelaide, Australia.
1994 Guidolin, A., Morona, J. K., Morona, R., Hansman, D., & Paton, J. C. (1994). Nucleotide sequence of genes essential for production of Streptococcus pneumoniae type 19F capsular polysaccharide. Poster session presented at the meeting of Australian Microbiologist. Melbourne, Australia.
1994 Guidolin, A., Morona, J. K., Morona, R., Hansman, D., & Paton, J. C. (1994). Analysis of genes essential for the production of Streptococcus pneumoniae type 19F capsular polysaccharide. Poster session presented at the meeting of Am. Soc. Microbiol. Fourth Int. Conf. Streptoccocal Genet. Sante Fe, New Mexico, USA.
1982 To, L., Haylock, D. N., Jedani, J. K., & Juttner, C. A. (1982). Optimal plating number in the peripheral blood CFUc assay. Poster session presented at the meeting of 19th Congress of the International Soociety of Haematology and the 17th Congress of the International Society of Blood Transfusion. Budapest, Hungary.
1982 Kirkland, M. A., Haylock, D. N., Jedani, J. K., & Juttner, C. A. (1982). The anomalous effects of lithium and some known inhibitors of myelopoiesis on neutropenic bone marrow in culture. Poster session presented at the meeting of Pathology. Adelaide, Australia.
1981 Haylock, D. N., Jedani, J. K., & Juttner, C. A. (1981). Collection of stem cells from peripheral blood in early remission in acute non-lymphoblastic leukaemia (ANLL). Poster session presented at the meeting of The Proceedings of the Australian Society for Medical Research. Canberra, Australia.
1981 Haylock, D. N., Kirkland, M. A., Jedani, J. K., & Juttner, C. A. (1981). High level of circulating progenitor cells in early remission from acute leukaemia. Poster session presented at the meeting of The Proceedings of the Australian Society for Medical Research. Canberra, Australia.

Year Citation
2024 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA (4). Canberra: Commonwealth of Australia.
2024 Merlin, T., Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Parsons, J., . . . Tamblyn, D. (2024). Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning. Canberra, ACT: Commonwealth of Australia.
DOI WoS12
2018 Kessels, S., Mittal, R., Morona, J., Newton, S., Schubert, C., Milverton, J., & Merlin, T. (2018). Anti-Müllerian hormone testing for female patients preceding or following gonadotoxic treatment (MSAC 1434).
2017 Morona, J., & Mittal, R. (2017). Substitution of 68Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369: Mini-assessment Report (Mini-assessment Report).
2017 Morona, J., Mittal, R., Newton, S., Salinger, K., Carter, D. A., Schubert, C., & Merlin, T. (2017). Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility (MSAC 1435 Part A, Assessment Report). Canberra: Commonwealth of Australia.
2017 Mittal, R., Kessels, S., Newton, S., Milverton, J., Parsons, J., Morona, J., . . . Merlin, T. (2017). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene - Resubmission (MSAC application 1216.1). Canberra: Commenwealth of Australia.
2016 Morona, J., Vogan, A., Kessels, S., Newton, S., Pridham, L., Ellery, B., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected non-ischaemic cardiomyopathies (MSAC 1432). Canberra.
2016 Morona, J., Kessels, S., Vogan, A., Mittal, R., Newton, S., Parsons, J., . . . Merlin, T. (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease (MSAC application number 1237). Canberra, ACT: Commonwealth of Australia.
2016 Kessels, S., Mittal, R., Morona, J., Newton, S., Ellery, B., Milverton, J., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies (MSAC Application no. 1393). Canberra, ACT: Commonwealth of Australia.
2015 Kessels, S., Morona, J., Mittal, R., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2015). Testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene (1216). http://www.msac.gov.au/internet/msac/publishing.nsf/Content/B1083E11E4A3006BCA257BCB0081849E/$File/1216-MSAC-CA-CFTR.pdf: Commonwealth of Australia.
2014 Ellery, B., Milverton, J., Newton, S., Morona, J. K., Gum, D., Parsons, J., . . . Merlin, T. (2014). Retinal photography with a non-mydriatic retinal camera in people with diabetes (MSAC Application number 1181). Canberra, ACT.: Commonwealth of Australia.
2014 Kessels, S., Schubert, C., Parsons, J., Morona, J. K., & Merlin, T. (2014). Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year (MSAC Application number 1162). Canberra, ACT.: Commonwealth of Australia.
2014 Morona, J. K., Vogan, A., Kessels, S., Gum, D., Milverton, J., Parsons, J., . . . Merlin, T. (2014). Nucleic acid amplification testing for active mycobacterial infection (MSAC Application number 1234). Canberra, ACT.: Commonwealth of Australia.
2014 Parsons, J., Vogan, A., Morona, J. K., Schubert, C., & Merlin, T. (2014). HBA1c test for the diagnosis of diabetes mellitus (MSAC Application 1267). Canberra, ACT.: Commonwealth of Australia.
2013 Newton, S., Schubert, C., Morona, J. K., Fitzgerald, P., & Merlin, T. (2013). Genetic testing for hereditary mutations in the RET gene. (MSAC Application 1152). Canberra, ACT.: Commonwealth of Australia.
2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.
2011 Buckley, E., Docter, S., Morona, J., Reddin, E., Mnatzaganian, G., Juneja, V., & Merlin, T. L. (2011). Prevention, Identification and Management of Foot Complications in Diabetes: Technical Report. Canberra, ACT: Commonwealth of Australia.

Year Citation
2015 Authors: Morona J, Tamblyn D, Ellery B, Merlin T. Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Description: N/A. Extent: N/A.
2013 Authors: Phoenix Australia - Centre for Postraumatic Mental Health. Title: Australian guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. Description: N/A. Extent: N/A.
2012 Authors: Newton S, Parsons J, Ellery B, Milverton J, Morona J, Docter S, Liufu Z, Merlin TL. Title: Update of the Australian guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder. Description: N/A. Extent: N/A.
2011 Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T. Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes. Description: N/A. Extent: N/A.

Year Citation
1999 Morona, J. K. (1999). Characterisation of the capsular polysaccharide biosynthesis loci of Streptococcus pneumoniae serogroup 19. (PhD Thesis, University of Adelaide).

Date Institution Department Organisation Type Country
2018 - 2023 National Health and Medical Research Council National Health and Medical Research Council Health services and related Australia

Connect With Me

External Profiles

Other Links